Quarterly report pursuant to Section 13 or 15(d)

EQUITY - Schedule of Equity Instruments Other than Options (Details)

v3.24.3
EQUITY - Schedule of Equity Instruments Other than Options (Details) - $ / shares
 1 Months Ended 9 Months Ended
Jul. 31, 2024
Feb. 29, 2024
Sep. 30, 2024
Nonvested, Number of Shares      
Granted (in shares)     21,900,000
Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)     86,931,558
Granted (in shares) 19,400,000 1,800,000  
Cancelled/forfeited/expired (in shares)     (416,667)
Issued and outstanding at end of period (in shares)     108,414,891
Weighted - Average Exercise Price      
Issued and outstanding at beginning of period (in dollars per share)     $ 1.12
Granted, weighted-average per share grant date fair value (in dollars per share)     0.99
Cancelled/forfeited/expired (in dollars per share)     1.56
Issued and outstanding at end of period (in dollars per share)     $ 1.09
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares)     106,504,891
Weighted - Average Exercise Price, Exercisable (in dollars per share)     $ 1.10
Warrants | Non-Derivative (Equity) Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)     49,068,636
Granted (in shares)     2,500,000
Cancelled/forfeited/expired (in shares)     (416,667)
Issued and outstanding at end of period (in shares)     51,151,969
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares)     49,241,969
Warrants | Derivative Liabilities Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)     37,862,922
Granted (in shares)     19,400,000
Cancelled/forfeited/expired (in shares)     0
Issued and outstanding at end of period (in shares)     57,262,922
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares)     57,262,922